Featured,Trends & Articles Oregon Releases First Set of Rules for its Therapeutic Psilocybin Program By Dennis Mutua February 15, 2022 Newly created Oregon Psilocybin Services section of the Oregon Health Authority has released the draft rules for the state’s therapeutic psilocybin program. This comes at a time when the state is preparing to launch its legal ps...
Featured,Spotlight Stock,Trends & Articles Health Canada Includes Mydecine’s Dealer License as a Supplier for the SAP in Canada By Dennis Mutua February 09, 2022 Biotechnology and digital technology developing innovative second and third generation novel compounds to treat mental health and addiction Mydecine Innovations Group. (NEO: MYCO) (OTCMKTS: MYCOF) announced that its exclusive deal...
Featured,Spotlight Stock,Trends & Articles Psyence Receives ISO Certification for its Natural Psilocybin Production Facility through BSI By Dennis Mutua February 08, 2022 Life science biotechnology company specializing on using naturally extracted psilocybin for long-term treatment of trauma and its mental health results Psyence Group Inc. (CSE: PSYG) (OTCQB: PSYGF) announced having receives Intern...
Featured,Spotlight Stock,Trends & Articles Entheon Biomedical Granted Approval for DMT Clinical Trial By Dennis Mutua February 04, 2022 Biotechnology company focused on research and development of psychedelics medicines to provide personalized treatment for addiction disorders Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) announced having being granted appro...
Featured,Trends & Articles University of Texas Launches Psychedelic Research and Therapy Center in Austin By Dennis Mutua January 31, 2022 University of Texas announced that its researchers at Austin’s Dell Medical School recently launched a psychedelic research and therapy center. The center was unveiled last week and it will be the first of its kind in Texas. ...
Featured,Trends & Articles Colorado Activists Pushing for Psilocybin Legalization to Appear on 2022 Ballot By Dennis Mutua January 28, 2022 Activists from Colorado State are pushing a psilocybin legalization act to appear on the 2022 ballot. According to the activists, they want to create a series of state licensed ‘healing centers’ where patients will be able to ...
Featured,Spotlight Stock,Trends & Articles Awakn Submits Patent Application For a New Series of Entactogen-Like Molecules to Treat Multiple Addictions By Dennis Mutua January 27, 2022 Biotechnology company running clinical operations, researching, developing and delivering psychedelic medicines to treat addictions Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) announced having submitted a patent applicati...
Featured,Trends & Articles Psychedelic Company Eleusis to go Public via Merger Deal With SPAC Silver Spike Acquisition Corp. II By Dennis Mutua January 24, 2022 Biotechnology company focused on transforming psychedelics into medicines Eleusis Inc. will be going public after a merger deal with a publicly traded special purpose acquisition company (SPAC) known as Silver Spike Acquisition Co...